Ventyx Biosciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Ventyx Biosciences, Inc. (VTYX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-135.12-192.96-108.43-83.75-28.17
Depreciation & Amortization1.350.940.470.030.00
Stock Based Compensation22.9328.5916.572.730.05
Change in Working Capital-10.565.81-5.164.020.81
Change in Accounts Payable-2.64-0.751.612.440.59
Change in Other Working Capital-7.926.55-6.7727.270.22
Other Operating Activities-9.4719.6314.0227.2721.12
Net Cash from Operating Activities-130.87-166.52-98.77-38.65-6.20
Investing Activities
Capital Expenditures-0.24-0.51-0.28-0.260.00
Acquisitions0.000.000.001.900.00
Purchases of Investments-283.65101.45-347.24-232.500.00
Sales/Maturities of Investments268.39373.73272.5816.500.00
Net Cash from Investing Activities-15.51100.94-74.93-214.370.00
Financing Activities
Common Stock Issued95.0553.33165.40158.820.00
Other Financing Activities27.070.000.000.000.00
Net Cash from Financing Activities122.1253.33167.77323.556.13
Summary
Effect of Forex Changes on Cash-0.06-0.01-0.040.010.00
Net Change in Cash-24.32-12.27-5.9370.54-0.07
Cash at Beginning of Period52.5564.8270.790.240.00
Cash at End of Period28.2452.5564.8270.790.00
Free Cash Flow-131.11-167.04-99.05-38.91-6.20
Supplemental Disclosures
Income Taxes Paid0.000.000.000.000.00